Operating Lease, Right-of-Use Asset of REGENXBIO Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
REGENXBIO Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • REGENXBIO Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $48,820,000, a 12% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

REGENXBIO Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $48,820,000 -$6,473,000 -12% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $50,469,000 -$5,875,000 -10% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $52,112,000 -$5,446,000 -9.5% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $53,716,000 -$6,771,000 -11% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $55,293,000 -$6,480,000 -10% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $56,344,000 -$6,092,000 -9.8% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $57,558,000 -$6,168,000 -9.7% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $60,487,000 -$4,629,000 -7.1% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $61,773,000 +$2,302,000 +3.9% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $62,436,000 +$2,273,000 +3.8% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $63,726,000 +$3,801,000 +6.3% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $65,116,000 +$4,212,000 +6.9% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $59,471,000 -$2,271,000 -3.7% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $60,163,000 -$2,117,000 -3.4% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $59,925,000 -$2,682,000 -4.3% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $60,904,000 -$2,911,000 -4.6% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $61,742,000 +$3,915,000 +6.8% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $62,280,000 +$53,645,000 +621% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $62,607,000 +$53,232,000 +568% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $63,815,000 +$53,737,000 +533% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $57,827,000 +$51,922,000 +879% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $8,635,000 +$2,731,000 +46% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $9,375,000 +$2,517,000 +37% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $10,078,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $5,905,000 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $5,904,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $6,858,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.